Most cases of CML are characterized by the presence of the Philadelphia chromosome, the reciprocal translocation of chromosomes 9 and 22 that generates the bcr–abl fusion gene encoding a constitutively active p210 Bcr–Abl tyrosine kinase1, 2. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.